Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Murray Stewart
ResearcherPublications, citations & collaboration network
Murray Stewart is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 89 works, 6,746 citations, an h-index of 36 and an i10-index of 59.
89
Works
6,746
Citations
36
h-index
59
i10-index
IDs:OpenAlex
How has Murray Stewart's publication output changed over time?
ScholarIQpublication output · 2008–2020
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2020.
1
2
5
1
1
1
200820092014201620182020
What are the most-cited papers on Murray Stewart?
ScholarIQmost cited works
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, Ralph B. D’Agostino, Christopher B. Granger, Nigel C. Jones, Lawrence A. Leiter, Anne E Rosenberg, Kristina N. Sigmon, Matthew C. Somerville, Karl M. Thorpe, John J.V. McMurray, Stefano Del Prato, Stefano Del Prato, John J.V. McMurray, Ralph B. D’Agostino, Christopher B. Granger, Adrian F. Hernandez, Salim Janmohamed, Lawrence A. Leiter, Robert M. Califf, Rury R. Holman, David L. DeMets, Matthew C. Riddle, Shaun G. Goodman, Darren K. McGuire, Karen Alexander, Adam D. DeVore, Chiara Melloni, Chetan B. Patel, David C. M. Kong, Gerald S. Bloomfield, Matthew T. Roe, Pierluigi Tricoci, Robert W. Harrison, Renato D. Lópes, Robin Mathews, Rajendra Mehta, W. Schuyler Jones, Sreekanth Vemulapalli, Thomas J. Povsic, Zubin J. Eapen, Keith Dombrowski, Brad J. Kolls, J. Dedrick Jordan, Andrew P. Ambrosy, Stephen J. Greene, Aditya Mandawat, Jay Shavadia, Lauren B. Cooper, Abhinav Sharma, Patrícia O. Guimarães, Daniel J. Friedman, Matthew E. Wilson, Patricia Endsley, Tracy Gentry, Jeannie Collier, Kathleen Perez, K.E. James, Jennifer Roush, C. ARDEN III POPE, Christina Howell, Megan Johnson, M. Bailey, Joanna Cole, Teresa Akers, Beth Vandyne, Betsy Thomas, Jenny Rich, Susan Bartone, Gail Beaulieu, Kim Brown, Tuan Chau, Tamra Christian, Rebecca Coker, Deb Greene, Trevorlyn Haddock, Wendy Jenkins, Ghazala Haque, Marsha L. Marquess, Jean Pesarchick, Renee Rethaford, Allegra Stone, Firas Al- Kawas, Michelle A. Anderson, Robert Enns, Isaac Sinay, Chantal Mathieu, Victor Yordanov, Irene Hramiak, Martin Haluzı́k, Søren Galatius, Bruno Guerci, Michael A. Nauck, Ilias Migdalis, Choon Beng Kathryn Tan, Győző Kocsis, Andrea Giaccari, Moon Kyu Lee, Ernesto Muñoz
The Lancet. 20181,822 CitationsOPEN ACCESS
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
Karine Clément, Erica L T van den Akker, Jesús Argente, Allison Bahm, Wendy K Chung, Hillori Connors, Kathleen De Waele, I. Sadaf Farooqi, Julie Gonneau-Lejeune, Gregory Gordon, Katja Kohlsdorf, Christine Poitou, Lia Puder, James Swain, Murray Stewart, Guojun Yuan, Martin Wabitsch, Peter Kühnen, Patricia Pigeon-Kherchiche, Anna Flaus-Furmaniuk, Martin Bald, Christian Denzer, Julia von Schnurbein, Ozair Abawi, Ulrike Blume‐Peytavi, Philipp Krabusch, Knut Mai, Dirk Schnabel, Susanna Wiegand, Christa E. Flück, Esther Schulz, Egbert Voß, Nataša Bratina, Katja Weiß, Gabriel Ángel Martos‐Moreno, Alban Danset, Paul Gougis, Béatrice Dubern, Karine Clément, Erica L T van den Akker, Jesús Argente, Allison Bahm, Wendy K Chung, Hillori Connors, Kathleen De Waele, I. Sadaf Farooqi, Julie Gonneau-Lejeune, Gregory Gordon, Christine Poitou, Lia Puder, James Swain, Murray Stewart, Goujun Yuan, Martin Wabitsch, Peter Kühnen
The Lancet Diabetes & Endocrinology. 2020472 Citations
Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
Richard E. Pratley, Michael A. Nauck, Anthony Barnett, Mark N. Feinglos, Fernando Ovalle, Illana Harman-Boehm, June Ye, Rhona Scott, Susan Johnson, Murray Stewart, Julio Rosenstock
The Lancet Diabetes & Endocrinology. 2014326 Citations
Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes
Julio Rosenstock, Jane E.B. Reusch, Mark Bush, Fred Yang, Murray Stewart, for the Albiglutide Study Group
Diabetes Care. 2009237 CitationsOPEN ACCESS
HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin
Bo Åhrén, Susan Johnson, Murray Stewart, Deborah T. Cirkel, Fred Yang, Caroline Perry, Mark N. Feinglos
Diabetes Care. 2014227 Citations
Related on ScholarIQ
Cleveland Clinic
Institution
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Paper
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
Paper
Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
Paper
Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes
Paper
HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin
Paper